HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark E Bardgett Selected Research

Mark E Bardgett Research Topics

Disease

3Schizophrenia (Dementia Praecox)
11/2010 - 07/2008
2Mental Disorders (Mental Disorder)
01/2019 - 03/2015
2Autistic Disorder (Autism)
03/2015 - 06/2013
2Alzheimer Disease (Alzheimer's Disease)
01/2011 - 07/2008
2Memory Disorders (Memory Loss)
07/2008 - 04/2003
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2020
1Conduct Disorder (Conduct Disorders)
11/2020
1Weight Gain
06/2013
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
05/2013
1Synucleinopathies
05/2013
1Kufor-Rakeb syndrome
05/2013
1Ataxia (Dyssynergia)
11/2010
1Hypersensitivity (Allergy)
03/2005
1Shock
04/2003
1Cognitive Dysfunction
04/2003

Drug/Important Bio-Agent (IBA)

4Antipsychotic Agents (Antipsychotics)IBA
11/2020 - 06/2013
4Dizocilpine Maleate (Dizocilpine)IBA
11/2010 - 04/2003
3Risperidone (Risperdal Consta)FDA LinkGeneric
11/2020 - 06/2013
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2009 - 04/2003
2ciproxifanIBA
01/2011 - 11/2010
2N-Methylaspartate (NMDA)IBA
07/2008 - 03/2005
1SynucleinsIBA
05/2013
1LipofuscinIBA
05/2013
1P-type ATPasesIBA
05/2013
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2011
1Phencyclidine (Angel Dust)IBA
07/2008
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
07/2008
1Clonidine (ST 155)FDA LinkGeneric
07/2008
1Glutamic Acid (Glutamate)FDA Link
07/2008
1Glutamate Receptors (Glutamate Receptor)IBA
03/2005